Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2014 09:00 ET | Source: Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Submits New Drug Application for Rextoro (formerly CLR-610) for the treatment of Low Testosterone

Northbrook, Ill, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., today announced the submission of a New Drug Application (NDA) for Rextoro™ (formerly CLR-610), the Company's oral...